bf/NASDAQ:ALPN_icon.jpeg

NASDAQ:ALPN

Alpine Immune Sciences, Inc.

  • Stock

USD

Last Close

64.96

17/05 20:00

Market Cap

4.46B

Beta: 1.26

Volume Today

4.29M

Avg: 76.25K

PE Ratio

−24.74

PFCF: −20.65

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-16.20M
-
-15.04M
7.17%
-22.82M
51.76%
-31.46M
37.89%
-7.78M
75.26%
-36.49M
368.80%
-41.85M
14.70%
-27.94M
33.24%
-50.33M
80.15%
-57.76M
14.76%
-32.18M
44.28%
depreciation and amortization
219K
-
86.44K
60.53%
66K
23.65%
143K
116.67%
241K
68.53%
388K
61.00%
468K
20.62%
578K
23.50%
620K
7.27%
597K
3.71%
-7.47M
1,352.09%
deferred income tax
-9K
-
-294.37K
3,170.72%
-1.34M
356.24%
-3.26M
142.96%
-204K
93.75%
-305K
49.51%
-344K
12.79%
108K
131.40%
910K
742.59%
46K
94.95%
155K
236.96%
stock based compensation
98K
-
69.63K
28.95%
1.34M
1,828.85%
3.26M
142.96%
838K
74.32%
2.31M
175.54%
3.04M
31.70%
4.14M
36.14%
6.24M
50.72%
9.65M
54.62%
10.63M
10.18%
change in working capital
1.08M
-
17.97K
98.33%
2.20M
12,154.44%
1.80M
18.35%
-3.35M
286.54%
4.67M
239.27%
3.20M
31.47%
52.94M
1,553.76%
27.04M
48.92%
4.19M
84.50%
6.74M
60.88%
accounts receivables
24.60M
-
225K
99.09%
inventory
accounts payables
400K
-
258.25K
35.44%
65K
74.83%
927K
1,326.15%
66K
92.88%
1.52M
2,207.58%
816K
46.42%
-491K
160.17%
5.97M
1,315.89%
5.56M
6.92%
6.52M
17.31%
other working capital
676K
-
-240.28K
135.54%
2.14M
989.36%
871K
59.24%
-3.42M
492.65%
3.15M
192.05%
2.38M
24.24%
53.43M
2,140.17%
21.07M
60.56%
-25.97M
223.24%
-6.74M
74.03%
other non cash items
521K
-
708.52K
35.99%
1.34M
89.55%
3.26M
142.96%
-6.31M
293.38%
1.01M
115.97%
140K
86.11%
261K
86.43%
274K
4.98%
-475K
273.36%
-50.14M
10,455.37%
net cash provided by operating activities
-14.29M
-
-14.45M
1.08%
-19.21M
32.94%
-26.26M
36.72%
-16.57M
36.89%
-28.42M
71.47%
-35.35M
24.39%
30.08M
185.11%
-15.25M
150.68%
-43.75M
186.95%
-79.01M
80.58%
investments in property plant and equipment
-125K
-
-4.10K
96.72%
-188K
4,485.37%
-106K
43.62%
-586K
452.83%
-495K
15.53%
-821K
65.86%
-802K
2.31%
-118K
85.29%
-412K
249.15%
-487K
18.20%
acquisitions net
31.13M
-
-17.58M
-
72.02M
509.56%
52.36M
27.29%
112.94M
115.68%
purchases of investments
-76.26M
-
-75.32M
1.23%
-88.31M
17.24%
-72.86M
17.49%
-59.38M
18.50%
-101.33M
70.64%
-133.52M
31.77%
-266.98M
99.96%
-351.35M
31.60%
sales maturities of investments
14M
-
100.73M
619.54%
27.96M
72.24%
105.23M
276.34%
76.97M
26.86%
29.31M
61.92%
81.16M
176.88%
154.05M
89.82%
296.27M
92.33%
other investing activites
250K
-
17.58M
6,933.60%
-72.02M
509.56%
-52.36M
27.29%
-112.94M
115.68%
net cash used for investing activites
-125K
-
-4.10K
96.72%
-62.45M
1,523,021.95%
25.30M
140.52%
-29.80M
217.78%
32.12M
207.77%
16.76M
47.81%
-72.82M
534.40%
-52.48M
27.93%
-113.35M
115.98%
-55.56M
50.98%
debt repayment
-1.19M
-
-3.14M
164.06%
-1M
-
-1.33M
33.30%
-5M
275.09%
-2.40M
52%
-4.80M
100%
common stock issued
12M
-
11.87M
1.10%
78.77M
563.73%
20K
99.97%
37.67M
188,230%
23.60M
-
56.26M
138.40%
102.66M
82.48%
106.72M
3.95%
161.91M
51.72%
common stock repurchased
dividends paid
other financing activites
32.44M
-
63K
99.81%
146K
131.75%
5.02M
3,339.73%
9K
99.82%
1.99M
22,011.11%
10.12M
408.69%
502K
95.04%
773K
53.98%
3.22M
316.17%
net cash used provided by financing activities
10.81M
-
41.17M
280.78%
78.83M
91.50%
166K
99.79%
42.69M
25,615.66%
-991K
102.32%
24.25M
2,547.53%
61.38M
153.07%
100.76M
64.16%
102.69M
1.91%
165.12M
60.80%
effect of forex changes on cash
-6K
-
58K
1,066.67%
-88K
251.72%
-118K
34.09%
8K
106.78%
net change in cash
-3.61M
-
26.71M
840.61%
-2.82M
110.56%
-788K
72.07%
-3.69M
367.89%
2.71M
173.53%
5.67M
109.00%
18.70M
230.11%
32.95M
76.15%
-54.53M
265.51%
30.56M
156.04%
cash at beginning of period
4.71M
-
1.10M
76.67%
27.81M
2,433.22%
24.99M
10.14%
11.82M
52.71%
8.13M
31.20%
10.84M
33.34%
16.51M
52.25%
35.21M
113.30%
68.16M
93.57%
13.63M
80.00%
cash at end of period
1.10M
-
27.81M
2,432.93%
24.99M
10.14%
24.20M
3.15%
8.13M
66.40%
10.84M
33.34%
16.51M
52.25%
35.21M
113.30%
68.16M
93.57%
13.63M
80.00%
44.19M
224.20%
operating cash flow
-14.29M
-
-14.45M
1.08%
-19.21M
32.94%
-26.26M
36.72%
-16.57M
36.89%
-28.42M
71.47%
-35.35M
24.39%
30.08M
185.11%
-15.25M
150.68%
-43.75M
186.95%
-79.01M
80.58%
capital expenditure
-125K
-
-4.10K
96.72%
-188K
4,485.37%
-106K
43.62%
-586K
452.83%
-495K
15.53%
-821K
65.86%
-802K
2.31%
-118K
85.29%
-412K
249.15%
-487K
18.20%
free cash flow
-14.42M
-
-14.45M
0.24%
-19.39M
34.20%
-26.36M
35.94%
-17.16M
34.92%
-28.91M
68.50%
-36.17M
25.10%
29.28M
180.96%
-15.37M
152.48%
-44.17M
187.43%
-79.50M
80.00%

All numbers in USD (except ratios and percentages)